Niche instrumentation MSI develops patented in vivo research instruments (ECGenie and DigiGait) with applications across CNS, pain, and neurodegenerative disease models, presenting a targeted opportunity to upsell to institutions conducting preclinical studies in these areas.

Prestigious customer base Customer list includes top-tier academic medical centers and major pharma players (Harvard Medical School, NIH, Pfizer, Icahn Mount Sinai), signaling credibility and potential for multi-site expansions, sponsored projects, and long-term procurement relationships.

Growing demand Reported multiple customers and a rapidly growing demand for efficient in vivo technologies indicate opportunities to expand footprint within existing accounts and nearby research hubs, including international institutions.

Global opportunities With customers in Europe, Asia, and Australia, MSI has a global market presence that can be leveraged to pursue regional distributors, cross-border collaborations, and localized support services to accelerate adoption.

Revenue range Current revenue is $10M-$25M across a small team, suggesting a high-value product model with potential for channel partnerships, larger enterprise deals, and scalable service offerings to increase average contract value.